213 related articles for article (PubMed ID: 28000772)
1. Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients.
Kuske A; Gorges TM; Tennstedt P; Tiebel AK; Pompe R; Preißer F; Prues S; Mazel M; Markou A; Lianidou E; Peine S; Alix-Panabières C; Riethdorf S; Beyer B; Schlomm T; Pantel K
Sci Rep; 2016 Dec; 6():39736. PubMed ID: 28000772
[TBL] [Abstract][Full Text] [Related]
2. Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer.
Meyer CP; Pantel K; Tennstedt P; Stroelin P; Schlomm T; Heinzer H; Riethdorf S; Steuber T
Urol Oncol; 2016 May; 34(5):235.e11-6. PubMed ID: 26795608
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays.
Budna-Tukan J; Świerczewska M; Mazel M; Cieślikowski WA; Ida A; Jankowiak A; Antczak A; Nowicki M; Pantel K; Azria D; Zabel M; Alix-Panabières C
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31185699
[TBL] [Abstract][Full Text] [Related]
4. Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients.
Markou A; Lazaridou M; Paraskevopoulos P; Chen S; Świerczewska M; Budna J; Kuske A; Gorges TM; Joosse SA; Kroneis T; Zabel M; Sedlmayr P; Alix-Panabières C; Pantel K; Lianidou ES
Clin Chem; 2018 Feb; 64(2):297-306. PubMed ID: 29122836
[TBL] [Abstract][Full Text] [Related]
5. The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study.
Theil G; Fischer K; Weber E; Medek R; Hoda R; Lücke K; Fornara P
PLoS One; 2016; 11(8):e0158354. PubMed ID: 27479125
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
7. Assessment of circulating tumor cells (CTCs) in prostate cancer patients with low-volume tumors.
Ali A; Furusato B; Ts'o PO; Lum ZP; Elsamanoudi S; Mohamed A; Srivastava S; Moul JW; Brassell SA; Sesterhenn IA; McLeod DG
Pathol Int; 2010 Oct; 60(10):667-72. PubMed ID: 20846264
[TBL] [Abstract][Full Text] [Related]
8.
Theil G; Boehm C; Fischer K; Bialek J; Hoda R; Weber E; Schönburg S; Kawan F; Fornara P
Oncol Lett; 2021 May; 21(5):357. PubMed ID: 33747214
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cell detection in high-risk non-metastatic prostate cancer.
Loh J; Jovanovic L; Lehman M; Capp A; Pryor D; Harris M; Nelson C; Martin J
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2157-62. PubMed ID: 25028119
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients.
Ramirez JM; Fehm T; Orsini M; Cayrefourcq L; Maudelonde T; Pantel K; Alix-Panabières C
Clin Chem; 2014 Jan; 60(1):214-21. PubMed ID: 24255082
[TBL] [Abstract][Full Text] [Related]
11. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
[TBL] [Abstract][Full Text] [Related]
12. Detection of Circulating Tumor Cells in Locally Advanced High-risk Prostate Cancer During Neoadjuvant Chemotherapy and Radical Prostatectomy.
Thalgott M; Rack B; Horn T; Heck MM; Eiber M; Kübler H; Retz M; Gschwend JE; Andergassen U; Nawroth R
Anticancer Res; 2015 Oct; 35(10):5679-85. PubMed ID: 26408743
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Detection of Circulating Tumor Cells in High-Risk Non-Metastatic Prostate Cancer Patients Undergoing Radiotherapy.
Chen S; Tauber G; Langsenlehner T; Schmölzer LM; Pötscher M; Riethdorf S; Kuske A; Leitinger G; Kashofer K; Czyż ZT; Polzer B; Pantel K; Sedlmayr P; Kroneis T; El-Heliebi A
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31277254
[TBL] [Abstract][Full Text] [Related]
14. Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer-Translational Research Results from the Prospective ProMPT trial.
Mandel PC; Huland H; Tiebel A; Haese A; Salomon G; Budäus L; Tilki D; Chun F; Heinzer H; Graefen M; Pantel K; Riethdorf S; Steuber T
Eur Urol Focus; 2021 Jan; 7(1):55-62. PubMed ID: 31178293
[TBL] [Abstract][Full Text] [Related]
15. Protocol for a prospective study evaluating circulating tumour cells status to predict radical prostatectomy treatment failure in localised prostate cancer patients (C-ProMeta-1).
Al-Hammouri T; Almeida-Magana R; Lawrence R; Duffy T; White L; Burke E; Kudahetti S; Collins J; Rajan P; Berney D; Gabe R; Shaw G; Lu YJ
BMC Cancer; 2023 Jun; 23(1):581. PubMed ID: 37353740
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of circulating tumor cell count in patients with metastatic hormone-sensitive prostate cancer.
Resel Folkersma L; San José Manso L; Galante Romo I; Moreno Sierra J; Olivier Gómez C
Urology; 2012 Dec; 80(6):1328-32. PubMed ID: 23063057
[TBL] [Abstract][Full Text] [Related]
17. Circulating Tumor Cells in Biochemical Recurrence of Prostate Cancer.
Aragon-Ching JB; Siegel RS; Frazier H; Andrawis R; Hendricks F; Phillips M; Jarrett T; Guebre-Xabiher H; Patierno S; Simmens SJ
Clin Genitourin Cancer; 2015 Oct; 13(5):e341-5. PubMed ID: 25956468
[TBL] [Abstract][Full Text] [Related]
18. Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer.
Cieślikowski WA; Budna-Tukan J; Świerczewska M; Ida A; Hrab M; Jankowiak A; Mazel M; Nowicki M; Milecki P; Pantel K; Alix-Panabières C; Zabel M; Antczak A
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31936460
[TBL] [Abstract][Full Text] [Related]
19. Detection of circulating tumor cells in colorectal cancer patients using the GILUPI CellCollector: results from a prospective, single-center study.
Dizdar L; Fluegen G; van Dalum G; Honisch E; Neves RP; Niederacher D; Neubauer H; Fehm T; Rehders A; Krieg A; Knoefel WT; Stoecklein NH
Mol Oncol; 2019 Jul; 13(7):1548-1558. PubMed ID: 31116510
[TBL] [Abstract][Full Text] [Related]
20. Capture of viable circulating tumor cells in the liver of colorectal cancer patients.
Denève E; Riethdorf S; Ramos J; Nocca D; Coffy A; Daurès JP; Maudelonde T; Fabre JM; Pantel K; Alix-Panabières C
Clin Chem; 2013 Sep; 59(9):1384-92. PubMed ID: 23695297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
